reduced sexual ability in both men and women), eye problems, such as changes or loss of vision, or gum disease associated with diabetes
Guidelines from the American Diabetes Association and the European Association for the Study of Diabetes recommend GLP-1 medications as preferred agents for patients with atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease
Taking it in the morning helps activate your metabolism early in the day, while post-workout use helps with muscle recovery and continued fat utilization
North America Leads GLP-1 Market with 75.46% Revenue Share in 2025 The report provides market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Like BPC-157, its not FDA-approved for human use, but its widely used in research and wellness/athletic circles
Glucagon-like peptide-1 agonists (GLP-1RA, GLP-1DAs, incretin mimetics, or GLP-1 analogs) represent a category of therapeutics used in the treatment of type 2 diabetes mellitus (T2DM) and obesity